NFKB1 and prostate carcinoma: The lectin-like LOX-1 receptor, which detects oxidized low-density lipoprotein and advanced glycation endproducts (AGE), signals to NF-κB in prostate cancer and could represent another mechanism for comorbidities between metabolic syndrome and prostate cancer [103].